Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients.

MLA

Yamamoto, Suguru, et al. “Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients.” PLoS ONE, vol. 10, no. 4, Apr. 2015, pp. 1–11. EBSCOhost, https://doi.org/10.1371/journal.pone.0122691.

APA

Yamamoto, S., Kido, R., Onishi, Y., Fukuma, S., Akizawa, T., Fukagawa, M., Kazama, J. J., Narita, I., & Fukuhara, S. (2015). Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients. PLoS ONE, 10(4), 1–11. https://doi.org/10.1371/journal.pone.0122691

Chicago

Yamamoto, Suguru, Ryo Kido, Yoshihiro Onishi, Shingo Fukuma, Tadao Akizawa, Masafumi Fukagawa, Junichiro J. Kazama, Ichiei Narita, and Shunichi Fukuhara. 2015. “Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients.” PLoS ONE 10 (4): 1–11. doi:10.1371/journal.pone.0122691.